Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy

This study has been completed.
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by:
Tuen Mun Hospital
ClinicalTrials.gov Identifier:
NCT00371956
First received: September 1, 2006
Last updated: September 15, 2010
Last verified: September 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2010
  Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):